Director/PDMR Shareholding

RNS Number : 8698I
Spire Healthcare Group PLC
06 April 2020
 

6 April 2020

 

Spire Healthcare Group plc (the "Company")

 

 

Acquisition of Spire Healthcare shares by Simon Rowlands

 

Between the 1 and 3 April 2020, Simon Rowlands purchased 258,000 ordinary shares in the Company at an average price of 77.19 pence each.

 

Following this announcement Simon Rowlands holds a total of 786,516 ordinary shares in the Company. The shares are held through a nominee.

 

Enquiries:

Philip Davies

Deputy Company Secretary

07803 508348

 

The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Simon Rowlands

2

Reason for the notification

a)

Position/status

 

Non Executive Director

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

b)

Nature of the transaction

Purchase of 258,000 ordinary shares at 77.19 pence each

c)

Price(s) and volume(s)

Price(s)

Volume(s)

77.19 pence

258,000


d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2020-04-01 to 2020-04-03

f)

Place of the transaction

XLON

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGLGDSGUGDGGL
UK 100

Latest directors dealings